Lapatinib for advanced breast cancer overexpressing HER2

Detalhes bibliográficos
Autor(a) principal: Afonso, Sergio L.
Data de Publicação: 2016
Outros Autores: Cataneo, Antonio José Maria [UNESP], de Oliveira Carvalho, Paulo Eduardo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1002/14651858.CD009713.pub2
http://hdl.handle.net/11449/228211
Resumo: This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the effectiveness and safety of lapatinib, used alone or in association with other drugs, improves the survival and the quality of life of woman with advanced breast cancer that overexpress the Human Epidermal Growth Factor Receptor 2 (HER2).
id UNSP_8233e316c760bff272682dfc05510f3d
oai_identifier_str oai:repositorio.unesp.br:11449/228211
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Lapatinib for advanced breast cancer overexpressing HER2This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the effectiveness and safety of lapatinib, used alone or in association with other drugs, improves the survival and the quality of life of woman with advanced breast cancer that overexpress the Human Epidermal Growth Factor Receptor 2 (HER2).Marilia Medical School Evidence Based Health Actions and Oncology, Sperendio Cabrini 295São Paulo State University Department of Surgery and Orthopedics, Distrito de Rubião Júnior, s/nMarilia Medical School Evidence Based Health Actions Department and Thoracic Surgery Department, Avenida Monte Carmelo, 800, Bairro FragataSão Paulo State University Department of Surgery and Orthopedics, Distrito de Rubião Júnior, s/nEvidence Based Health Actions and OncologyUniversidade Estadual Paulista (UNESP)Evidence Based Health Actions Department and Thoracic Surgery DepartmentAfonso, Sergio L.Cataneo, Antonio José Maria [UNESP]de Oliveira Carvalho, Paulo Eduardo2022-04-29T07:51:58Z2022-04-29T07:51:58Z2016-09-28info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1002/14651858.CD009713.pub2Cochrane Database of Systematic Reviews, v. 2016, n. 9, 2016.1469-493Xhttp://hdl.handle.net/11449/22821110.1002/14651858.CD009713.pub22-s2.0-84988811346Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengCochrane Database of Systematic Reviewsinfo:eu-repo/semantics/openAccess2022-04-29T07:51:58Zoai:repositorio.unesp.br:11449/228211Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462022-04-29T07:51:58Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Lapatinib for advanced breast cancer overexpressing HER2
title Lapatinib for advanced breast cancer overexpressing HER2
spellingShingle Lapatinib for advanced breast cancer overexpressing HER2
Afonso, Sergio L.
title_short Lapatinib for advanced breast cancer overexpressing HER2
title_full Lapatinib for advanced breast cancer overexpressing HER2
title_fullStr Lapatinib for advanced breast cancer overexpressing HER2
title_full_unstemmed Lapatinib for advanced breast cancer overexpressing HER2
title_sort Lapatinib for advanced breast cancer overexpressing HER2
author Afonso, Sergio L.
author_facet Afonso, Sergio L.
Cataneo, Antonio José Maria [UNESP]
de Oliveira Carvalho, Paulo Eduardo
author_role author
author2 Cataneo, Antonio José Maria [UNESP]
de Oliveira Carvalho, Paulo Eduardo
author2_role author
author
dc.contributor.none.fl_str_mv Evidence Based Health Actions and Oncology
Universidade Estadual Paulista (UNESP)
Evidence Based Health Actions Department and Thoracic Surgery Department
dc.contributor.author.fl_str_mv Afonso, Sergio L.
Cataneo, Antonio José Maria [UNESP]
de Oliveira Carvalho, Paulo Eduardo
description This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the effectiveness and safety of lapatinib, used alone or in association with other drugs, improves the survival and the quality of life of woman with advanced breast cancer that overexpress the Human Epidermal Growth Factor Receptor 2 (HER2).
publishDate 2016
dc.date.none.fl_str_mv 2016-09-28
2022-04-29T07:51:58Z
2022-04-29T07:51:58Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1002/14651858.CD009713.pub2
Cochrane Database of Systematic Reviews, v. 2016, n. 9, 2016.
1469-493X
http://hdl.handle.net/11449/228211
10.1002/14651858.CD009713.pub2
2-s2.0-84988811346
url http://dx.doi.org/10.1002/14651858.CD009713.pub2
http://hdl.handle.net/11449/228211
identifier_str_mv Cochrane Database of Systematic Reviews, v. 2016, n. 9, 2016.
1469-493X
10.1002/14651858.CD009713.pub2
2-s2.0-84988811346
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Cochrane Database of Systematic Reviews
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1803046810275545088